Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q1 FY25 results · Apr–Jun 2024
Metropolis Healthcare reported revenue from operations of ₹313.36 crore (up 13.1% from Q1 FY24) and net profit of ₹38.11 crore (up 31.5% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 313.36 | 277.09 | +13.1% | 331.00 | −5.3% |
| Other income | 2.46 | 3.05 | −19.5% | 2.54 | −3.2% |
| Total income | 315.81 | 280.14 | +12.7% | 333.54 | −5.3% |
| Profit before tax | 51.08 | 39.19 | +30.3% | 50.53 | +1.1% |
| Net profit for the period | 38.11 | 28.98 | +31.5% | 36.53 | +4.3% |
| Attributable to shareholders of the company | 37.95 | 28.80 | +31.8% | 36.41 | +4.2% |
| EPS, basic (₹) | 7.41 | 5.62 | +31.9% | 7.11 | +4.2% |
| Net margin (%) | 12.2 | 10.5 | 11.0 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 286.14 | 256.29 | +11.6% | 292.27 | −2.1% |
| Other income | 2.83 | 2.78 | +1.6% | 2.02 | +40.0% |
| Total income | 288.96 | 259.07 | +11.5% | 294.29 | −1.8% |
| Profit before tax | 41.72 | 35.23 | +18.4% | 45.05 | −7.4% |
| Net profit for the period | 31.28 | 26.13 | +19.7% | 31.78 | −1.6% |
| EPS, basic (₹) | 6.11 | 5.10 | +19.8% | 6.21 | −1.5% |
| Net margin (%) | 10.9 | 10.2 | 10.9 |
Consolidated
- Filed with BSE
- 13 Aug 2024, 16:19 IST
- Board meeting
- 10 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2024, 16:19 IST
- Board meeting
- 10 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE